Camber Capital Management LLC, 10% Owner at Protalix BioTherapeutics, Inc. (PLX), sold 2,500,000 shares at $0.32 ($800K) on 2016-12-02, disclosed to the SEC on 2016-12-06.
Open-market sale of $800k PLX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SQNM | BUY | 2016-01-04 | $1.7M | — | Filing → |
| SQNM | BUY | 2015-12-17 | $610K | — | Filing → |
| SQNM | BUY | 2015-12-16 | $28K | — | Filing → |